424B5NGNECIK 0001404644
Neurogene Inc.
Prospectus supplement (424B5) filed .
Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.
Filing facts
- Accession number
- 0001628280-26-046666
- Filer
- Neurogene Inc.
- Ticker
- NGNE
- CIK
- 0001404644
- Form type
- 424B5
- Form description
- Prospectus supplement
- Filed at
- July 2, 2026
- Last verified
- July 3, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1404644/000162828026046666/0001628280-26-046666-index.htm ↗Filer's full EDGAR submission history
EDGAR · Neurogene Inc. (0001404644) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001628280-26-046666.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.